About
Contact & Profiles
A5068183906
Research Areas
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- Neurogenetic and Muscular Disorders Research
Abstract Background Spinal muscular atrophy is a group of autosomal recessive inherited neurological disorders secondary to genetic mutation that leads progressive muscle weakness and atrophy. Recently approved by the Food Drug Administration, Nusinersen first treatment specifically for spinal This drug must be administered intrathecally, as it does not cross blood‐brain barrier. Aims Retrospective review individualized perioperative care type I II patients intrathecal injection. Methods...
10.1111/pan.13964
article
EN
Pediatric Anesthesia
2020-07-05
Coming Soon ...